Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TransNiDeG
2023-503349-71-00Phase 2Authorised
- Sponsor
- University of Bonn
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in gastroparesis comparing Nicotine patch with Placebo patch (2 arms). Primary endpoint: Grade of delayed gastric emptying. Planned start Oct 2023; status: authorised.
02
Drugs
nicotine
03
Conditions
gastroparesis
Beyond the preview
Go deeper on 2023-503349-71-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503349-71-00.